Stonepine Capital Management as of March 31, 2022
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 28 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 21.7 | $52M | 6.3M | 8.27 | |
| Cti Biopharma | 9.1 | $22M | 4.7M | 4.67 | |
| Xeris Pharmaceuticals (XERS) | 8.4 | $20M | 7.9M | 2.56 | |
| Amarin Corp Plc - Spons Adr New (AMRN) | 6.7 | $16M | 4.9M | 3.29 | |
| Ovid Therapeutics (OVID) | 5.5 | $13M | 4.2M | 3.14 | |
| Adma Biologics (ADMA) | 5.4 | $13M | 7.1M | 1.83 | |
| Antares Pharma | 5.3 | $13M | 3.1M | 4.10 | |
| Conformis | 4.5 | $11M | 17M | 0.62 | |
| Apollo Endosurgery | 4.3 | $10M | 1.7M | 6.05 | |
| Exagen (XGN) | 3.7 | $9.0M | 1.1M | 8.03 | |
| Enanta Pharmaceuticals (ENTA) | 3.5 | $8.5M | 120k | 71.18 | |
| Ligand Pharmaceuticals Com New (LGND) | 3.4 | $8.3M | 74k | 112.50 | |
| Optinose (OPTN) | 3.0 | $7.2M | 2.9M | 2.47 | |
| Quidel Corporation | 2.9 | $6.9M | 62k | 112.46 | |
| Evolus (EOLS) | 2.7 | $6.6M | 586k | 11.22 | |
| Atyr Pharma Com New (ATYR) | 1.3 | $3.2M | 602k | 5.35 | |
| Diamedica Therapeutics Com New (DMAC) | 1.2 | $3.0M | 1.2M | 2.50 | |
| Synlogic | 1.1 | $2.6M | 1.1M | 2.40 | |
| Rezolute Com New (RZLT) | 1.0 | $2.5M | 749k | 3.38 | |
| Urogen Pharma (URGN) | 1.0 | $2.3M | 269k | 8.71 | |
| Rti Biologics | 0.9 | $2.2M | 7.4M | 0.30 | |
| Celcuity (CELC) | 0.9 | $2.2M | 239k | 9.35 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.9 | $2.1M | 2.5M | 0.83 | |
| Xoma Corp Com New (XOMA) | 0.4 | $1.0M | 37k | 27.99 | |
| Aerie Pharmaceuticals | 0.4 | $854k | 94k | 9.09 | |
| Biosante Pharmaceuticals (ANIP) | 0.3 | $733k | 26k | 28.13 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.2 | $531k | 57k | 9.36 | |
| Neuroone Medical Technologie Com New (NMTC) | 0.1 | $273k | 248k | 1.10 |
